# Merck Acquires Verona, Virtual Cell Challenge, Gene Therapy Restores Hearing

Page: https://stenobird.com/podcast/touching-base-6714887/merck-acquires-verona-virtual-cell-challenge-gene-therapy-restores-hearing
Text version: https://stenobird.com/podcast/touching-base-6714887/merck-acquires-verona-virtual-cell-challenge-gene-therapy-restores-hearing.md
Podcast: [Touching Base](https://stenobird.com/podcast/touching-base-6714887)
Published: 2025-07-11T13:05:17+00:00
Episode link: https://shows.acast.com/touching-base/episodes/merck-acquires-verona-virtual-cell-challenge-gene-therapy-re
Audio file: https://sphinx.acast.com/p/open/s/65736d39d32e730012c98919/e/68701a3b2a194507630112ac/media.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/merck-acquires-verona-virtual-cell-challenge-gene-therapy-restores-hearing
Duration seconds: 1901

## Resource

Merck & Co. has acquired Verona Pharma for $10 billion in a deal designed to expand the pharma giant’s portfolio of cardio-pulmonary disease treatments. In a step toward virtual cell benchmarking, the Arc Institute has launched the Virtual Cell Challenge to evaluate the ability of transcriptome AI models to generalize to new cell contexts for therapeutic applications. Fujifilm rebrands life science companies to position itself as a drug development leader. Additionally, AAV- OTOF gene therapy shows promise in restoring hearing loss while a new proteomics tool gleams insight into telomere repair. We wrap up our episode with highlights from BIO 2025 , as FDA Commissioner Martin Makary, MD, shared his vision for a “New FDA” focused on accelerating drug applications, industry partnerships, and applying AI. Join GEN editors Corinna Singleman, PhD, Alex Philippidis, Fay Lin, PhD, and Uduak Thomas for a discussion of the latest biotech and biopharma news. Listed below are links to the GEN stories referenced in this episode of Touching Base :   Merck to Acquire Verona Pharma for $10B, Adding Fast-Growing COPD Drug By Alex Philippidis, GEN Edge, July 9, 2025 Arc Institute Launces Virtual Cell Challenge to Accelerate AI Model Development By Fay Lin, PhD, GEN Edge, June 26, 2025 End-to-End: Fujifilm Rebrands Life Sciences Companies, Positioning Itself as Drug Development Cycle Leader By Alex Philippidis, GEN Edge, July 8, 2025 AAV-OTOF Gene Therapy Trial Restores Hearing in Both Children and Adults   By GEN, July 7, 2025   Proteomics Tool Sheds Light on Cancer Cells’ Telomere Repair Tactics By GEN, July 7, 2025   Makary Calls for “New FDA” at BIO; Defends Agency’s Spring Job Cuts By Alex Philippidis, GEN Edge, June 18, 2025 Cell and Gene Therapy Leaders Te…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/merck-acquires-verona-virtual-cell-challenge-gene-therapy-restores-hearing/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/touching-base-6714887/merck-acquires-verona-virtual-cell-challenge-gene-therapy-restores-hearing.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.